Compare

CRA International/$CRAI

1D1W1M3M6MYTD1Y5YMAX

About CRA International

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.
Ticker
$CRAI
Sector
Business services
Primary listing
NASDAQ
Employees
1,028

CRAI Metrics

BasicAdvanced
$1.4B
27.29
$7.96
0.61
$2.28
1.05%

What the Analysts think about CRAI

Analyst ratings (Buy, Hold, Sell) for CRA International stock.
Analyst projections of the future price of CRA International stock.

Bulls say / Bears say

Third-quarter revenue rose 15.6% to a record $214.9 million, with seven practices representing about 95% of revenue growing; CRA raised its full-year revenue guidance to $830–840 million. That breadth gives the growth outlook support beyond a single practice. (The Motley Fool)
Average weekly project leads and new project originations each grew by more than 20% year on year, while utilisation reached 78% despite a 6.2% increase in consultant headcount. If CRA converts the stronger pipeline into billable work, it has room to sustain growth. (The Motley Fool)
CRA’s Energy practice is advising utilities, data-centre developers and investors on rising power and infrastructure needs. This offers a potential source of demand beyond litigation and antitrust work; management consulting revenue grew 9.8% in the quarter, with Energy and Life Sciences contributing. (The Motley Fool)
Profit growth is lagging the sales increase: third-quarter non-GAAP EBITDA rose 11.2%, but its margin fell to 12.6% from 13.1% a year earlier. CRA also expects about $15 million more forgivable-loan amortisation in fiscal 2026 as it invests in talent, which may keep costs elevated. (The Motley Fool)
A sharp sequential fall in worldwide M&A activity could eventually cool demand for CRA’s antitrust advice, even though that practice posted another record quarter. International revenue growth also slowed to 6.2% from rates above 20% in the preceding four quarters. (The Motley Fool)
Cash conversion is a concern: CRA used $43.9 million in operating cash year to date, more than the $37.6 million used a year earlier, while days sales outstanding rose to 117 from 100 at the end of the first quarter. Continued working-capital strain could limit financial flexibility. (StockTitan, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2026.

CRAI Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

CRAI Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.